CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105. A total of 39 filers reported holding CERULEAN PHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $24,000 | -46.7% | 33,883 | +103.1% | 0.00% | – |
| Q1 2016 | $45,000 | +25.0% | 16,684 | +30.5% | 0.00% | – |
| Q4 2015 | $36,000 | -25.0% | 12,780 | -2.2% | 0.00% | – |
| Q3 2015 | $48,000 | -71.1% | 13,063 | -63.7% | 0.00% | – |
| Q2 2015 | $166,000 | -64.8% | 35,992 | -31.2% | 0.00% | – |
| Q1 2015 | $471,000 | +70.7% | 52,284 | +17.6% | 0.00% | – |
| Q4 2014 | $276,000 | +47.6% | 44,451 | +0.2% | 0.00% | – |
| Q3 2014 | $187,000 | -32.7% | 44,346 | -7.6% | 0.00% | – |
| Q2 2014 | $278,000 | – | 47,980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,437,441 | $5,261,000 | 9.25% |
| Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $12,032,000 | 8.20% |
| Deer VII & Co. Ltd. | 166,675 | $610,000 | 0.58% |
| WALL STREET ASSOCIATES | 475,000 | $1,738,000 | 0.33% |
| Cormorant Asset Management, LP | 551,354 | $2,018,000 | 0.32% |
| Rock Springs Capital Management LP | 625,000 | $2,288,000 | 0.19% |
| Northeast Financial Consultants Inc | 40,000 | $146,000 | 0.07% |
| Granahan Investment Management | 377,277 | $1,381,000 | 0.04% |
| Donald L. Hagan, LLC | 10,000 | $37,000 | 0.03% |
| Alyeska Investment Group, L.P. | 284,501 | $1,041,000 | 0.01% |